Search research articles
Contact Us
Filters
Showing results (41-50 of 189) with videos related to
Page
of 19
Sort By:
Plos One
|
November 24, 2016
Synonymous Co-Variation across the E1/E2 Gene Junction of Hepatitis C Virus Defines Virion Fitness
Brendan A Palmer, Liam J Fanning
Gynecologic Oncology
|
September 28, 2000
Cisplatin-paclitaxel-cyclophosphamide with G-CSF in primary advanced epithelial ovarian cancer
J Fanning, M Colgrove, G Phibbs
Gynecologic Oncology
|
June 1, 2000
National Cancer Data Base/Surveillance Epidemiology and End Results: potential insensitive-measure bias
J Fanning, A Gangestad, S J Andrews
American Journal of Obstetrics and Gynecology
|
May 12, 2001
Prospective analysis of a fever evaluation algorithm after major gynecologic surgery
A Schwandt, S J Andrews, J Fanning
American Journal of Clinical Oncology
|
August 1, 1994
Carboplatin, etoposide, and ifosfamide as second-line treatment for ovarian cancer
J Fanning, R D Hilgers, E Hutson
Obstetrics and Gynecology
|
September 1, 1989
Fatal recurrent reexpansion pulmonary edema
J Fanning, L Lettieri, M S Piver
Gynecologic Oncology
|
December 31, 1997
Modified radical vulvectomy without lymphadenectomy under local anesthesia in medically compromised patients
K J Manahan, J Hudec, J Fanning
American Journal of Obstetrics and Gynecology
|
May 20, 2000
Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma
S Umhauer, R J Ruch, J Fanning
Gynecologic Oncology
|
November 1, 1994
Surgical stapling technique for radical hysterectomy
J Fanning, R D Hilgers, C Palabrica
British Medical Journal
|
August 27, 2010
THE RESULTS OF SANATORIUM TREATMENT
F W Burton-Fanning, W J Fanning
Page
of 19
Search research articles
Search
Showing results (41-50 of 189) with videos related to
Sort By:
Page
of 19
Plos One
|
November 24, 2016
Synonymous Co-Variation across the E1/E2 Gene Junction of Hepatitis C Virus Defines Virion Fitness
Brendan A Palmer, Liam J Fanning
Gynecologic Oncology
|
September 28, 2000
Cisplatin-paclitaxel-cyclophosphamide with G-CSF in primary advanced epithelial ovarian cancer
J Fanning, M Colgrove, G Phibbs
Gynecologic Oncology
|
June 1, 2000
National Cancer Data Base/Surveillance Epidemiology and End Results: potential insensitive-measure bias
J Fanning, A Gangestad, S J Andrews
American Journal of Obstetrics and Gynecology
|
May 12, 2001
Prospective analysis of a fever evaluation algorithm after major gynecologic surgery
A Schwandt, S J Andrews, J Fanning
American Journal of Clinical Oncology
|
August 1, 1994
Carboplatin, etoposide, and ifosfamide as second-line treatment for ovarian cancer
J Fanning, R D Hilgers, E Hutson
Obstetrics and Gynecology
|
September 1, 1989
Fatal recurrent reexpansion pulmonary edema
J Fanning, L Lettieri, M S Piver
Gynecologic Oncology
|
December 31, 1997
Modified radical vulvectomy without lymphadenectomy under local anesthesia in medically compromised patients
K J Manahan, J Hudec, J Fanning
American Journal of Obstetrics and Gynecology
|
May 20, 2000
Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma
S Umhauer, R J Ruch, J Fanning
Gynecologic Oncology
|
November 1, 1994
Surgical stapling technique for radical hysterectomy
J Fanning, R D Hilgers, C Palabrica
British Medical Journal
|
August 27, 2010
THE RESULTS OF SANATORIUM TREATMENT
F W Burton-Fanning, W J Fanning
Page
of 19